1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sri 63-441 in 55 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sri 63-441) | Trials (sri 63-441) | Recent Studies (post-2010) (sri 63-441) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 60 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (49.09) | 18.7374 |
1990's | 27 (49.09) | 18.2507 |
2000's | 1 (1.82) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Klachko, DM; Paul, A; Shukla, SD | 1 |
Bautista, AP; Spitzer, JJ | 1 |
Dodam, JR; Johnson, LW; Kruse-Elliott, KT; Olson, NC | 1 |
Chang, SW; Chen, CR; Voelkel, NF | 1 |
Dunoyer-Geindre, S; Girard, JP; Gumowski, PI; Ludi, F; Perez, T; Terki, N | 1 |
Ferrell, JB; Fleisher, LN; McGahan, MC; Smith, MG | 1 |
O'Neill, C; Ryan, JP; Spinks, NR | 1 |
Ammit, AJ; Fleming, S; Korth, R; O'Neill, C; Wells, X | 1 |
Caplan, MS; Hsueh, W; Sun, XM | 2 |
Fei, X; Gong, XQ; Li, SH; Wu, ZL | 2 |
Bradley, LM; Czaja, JF; Goldstein, RE; Stambouly, JJ | 1 |
Feuerstein, G; Gleason, MM; Hallenbeck, J; Yue, TL | 1 |
Felsen, D; Loo, MH; Marion, DN; Vaughan, ED | 1 |
Blair, IA; Christman, BW; Lefferts, PL; Snapper, JR | 1 |
Liu, T; Makowka, L; Nalesnik, M; Walsh, TR | 1 |
Braquet, P; Fecchio, D; Jancar, S; Russo, M; Sirois, P | 1 |
Hsueh, W; Sun, XM; Torre-Amione, G | 1 |
Håkansson, L; Venge, P | 1 |
Chapman, FA; Cramer, DV; Makowka, L; Qian, SG; Starzl, TE; Sun, H | 1 |
O'Neill, C; Spinks, NR | 2 |
Bigaud, M; Parratt, JR; Wainwright, CL | 2 |
Dhar, A; Morrison, WJ; Shukla, SD | 1 |
Bernstein, PR; Handley, DA; Harris, KE; Krell, RD; Patterson, R; Saunders, RN | 1 |
Moore, JN; Morris, DD | 1 |
Deacon, RW; Farley, C; Handley, DA; Houlihan, WJ; Hughes, JW; Jaeggi, C; Koletar, JM; Prashad, M; Tomesch, JC | 1 |
Morrison, WJ; Shukla, SD | 1 |
Harper, MJ; Norris, CJ; Woodard, DS | 1 |
Gerkens, JF | 1 |
Hahn, HL; Hümmer, B; Stenzel, H | 1 |
Anderson, GP; Fennessy, MR | 1 |
Makowka, L; Mazzaferro, V; Ontell, SJ; Ove, P; Starzl, TE; Trager, J | 1 |
Dabiri, GA; Shalit, M; Southwick, FS | 1 |
Davis, D; Fowler, AA; Glauser, FL; Sessler, CN | 1 |
Chang, SW; Haynes, J; Morris, KG; Voelkel, NF | 1 |
Rosenbaum, JT; Rubin, RM | 1 |
Rosenbaum, JT; Rubin, RM; Samples, JR | 1 |
Makowka, L; Ontell, SJ; Ove, P; Starzl, TE | 1 |
Banner, B; Chapchap, P; Esquivel, CO; Makowka, L; Mazzaferro, V; Miller, C; Pan, C; Podesta, L; Pressley, D; Todo, S | 1 |
Bagby, GJ; Dobrescu, C; Hargrove, DM; Lang, CH; Spitzer, JJ | 1 |
Chang, SW; Feddersen, CO; Henson, PM; Voelkel, NF | 1 |
Ballard, FH; Handley, DA; Jaffe, JM; Melden, MK; Saunders, RN; Tomesch, JC; Van Valen, RG | 1 |
Handley, DA; Harris, KE; Patterson, R; Saunders, RN | 1 |
Genovese, A; Levi, R; Robertson, DA | 1 |
Handley, DA; Saunders, RN; Tomesch, JC | 1 |
Heard, SO; Perkins, M; Toth, I | 1 |
Chen, SF; Ding, FY; Li, SH | 1 |
Berthiaume, N; Bkaily, G; Claing, A; D'Orléans-Juste, P; Rola-Pleszczynski, M; Sirois, P | 1 |
Chang, SW | 1 |
Caplan, MS; Hsueh, W; Sun, X | 1 |
Carrick, JB; Moore, JN; Morris, DD | 1 |
Caplan, M; Chang, H; Gonzalez-Crussi, F; Hsueh, W; Qu, XW; Tan, XD | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sri 63-441
Article | Year |
---|---|
Hypoxia, PAF, and necrotizing enterocolitis.
Topics: Animals; Azepines; Enterocolitis; Humans; Hypoxia; Intestines; Necrosis; Platelet Activating Factor; Quinolinium Compounds; Triazoles | 1991 |
54 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sri 63-441
Article | Year |
---|---|
Hypersensitivity of diabetic human platelets to platelet activating factor.
Topics: Blood Platelets; Diabetes Mellitus; Glycated Hemoglobin; Humans; Lipids; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Quinolines; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction | 1992 |
Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion.
Topics: Animals; Anions; Free Radicals; Ibuprofen; In Vitro Techniques; Kupffer Cells; Lipopolysaccharides; Liver; Male; Neutrophils; Peroxidase; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxides; Zymosan | 1992 |
Differential effects of WEB 2086 and SRI 63-441 on TNF-alpha-induced alterations in cardiopulmonary function.
Topics: Animals; Azepines; ErbB Receptors; Heart; Indomethacin; Lipids; Lung; Platelet Activating Factor; Platelet Aggregation; Quinolinium Compounds; Swine; Triazoles; Tumor Necrosis Factor-alpha | 1992 |
Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
Topics: Angiotensin II; Animals; Azepines; Hypoxia; In Vitro Techniques; Male; Phospholipid Ethers; Platelet Activating Factor; Pulmonary Circulation; Pulmonary Edema; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Triazoles; Vasoconstriction; Vasodilation | 1992 |
PAF acether release on antigenic challenge. A method for the investigation of drug allergic reactions.
Topics: Antigens; Aspirin; Drug Hypersensitivity; Humans; Immunoglobulin E; Leukocytes; Lidocaine; Lymphocyte Activation; Penicillins; Platelet Activating Factor; Platelet Aggregation; Predictive Value of Tests; Quinolinium Compounds; Radioallergosorbent Test; Sensitivity and Specificity; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Lipid mediators of tumor necrosis factor-alpha-induced uveitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Eicosanoids; Eye Proteins; Indomethacin; Leukocyte Count; Leukotriene B4; Male; Naproxen; Platelet Activating Factor; Prostaglandins E; Quinolinium Compounds; Rabbits; Recombinant Proteins; Tumor Necrosis Factor-alpha; Uveitis, Anterior; Vitreous Body | 1991 |
Antagonists of embryo-derived platelet-activating factor act by inhibiting the ability of the mouse embryo to implant.
Topics: Animals; Azepines; Blastocyst; Decidua; Embryo Implantation; Embryo Transfer; Epoprostenol; Female; Iloprost; Mice; Mice, Inbred Strains; Platelet Activating Factor; Pregnancy; Quinolinium Compounds; Triazines; Triazoles; Trophoblasts | 1990 |
The effect of inhibitors of platelet aggregation on the metabolism of platelet-activating factor (PAF) in washed rabbit platelets.
Topics: Animals; Azepines; Blood Platelets; Chromatography, High Pressure Liquid; Iloprost; Kinetics; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Quinolinium Compounds; Rabbits; Triazoles; Tritium | 1991 |
Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation.
Topics: Animals; Endotoxins; Escherichia coli; Female; Male; Microcirculation; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Shock, Septic; Splanchnic Circulation | 1991 |
Sustained effects of platelet-activating factor infusion in piglets.
Topics: Animals; Animals, Newborn; Azepines; Female; Hypoxia; Infusions, Intravenous; Male; Platelet Activating Factor; Pulmonary Circulation; Quinolinium Compounds; Swine; Triazoles; Vasoconstriction | 1991 |
Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells.
Topics: Animals; Azepines; Calcium; Calcium Channel Blockers; Cerebral Cortex; Cricetinae; Cricetulus; Cytosol; Diterpenes; Gallic Acid; Ginkgolides; Hybrid Cells; Lactones; Mice; Neuroblastoma; Platelet Activating Factor; Quinolinium Compounds; Triazoles | 1991 |
Effects of platelet-activating factor on rat mesenteric microcirculation.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Female; Male; Microcirculation; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Splanchnic Circulation | 1990 |
Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.
Topics: Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Dogs; Fatty Acids, Unsaturated; Female; Hydrazines; Platelet Activating Factor; Pressure; Prostaglandin Endoperoxides, Synthetic; Quinolinium Compounds; Receptors, Prostaglandin; Receptors, Thromboxane; Renal Circulation; Thromboxane A2; Ureter; Ureteral Obstruction; Vascular Resistance; Vasoconstriction | 1990 |
Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
Topics: Animals; Azepines; Consciousness; Cyclooxygenase Inhibitors; Endotoxins; Escherichia coli; Platelet Activating Factor; Platelet Membrane Glycoproteins; Premedication; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome; Sheep; Thromboxane-A Synthase; Triazoles | 1990 |
Improved preservation of the rat liver for orthotopic liver transplantation: use of University of Wisconsin-lactobionate solution and retrograde reflushing.
Topics: Adenosine; Allopurinol; Animals; Bile; Free Radical Scavengers; Glutathione; Hypertonic Solutions; Insulin; Liver; Liver Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Organ Size; Perfusion; Platelet Activating Factor; Quinolinium Compounds; Raffinose; Rats; Rats, Inbred Lew; Solutions; Survival Rate; Time Factors; Tissue Survival | 1990 |
Inhibition of Ehrlich ascites tumor in vivo by PAF-antagonists.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Adhesion; Cell Division; Diterpenes; Ginkgolides; Hydrogen Peroxide; Lactones; Macrophages; Male; Mice; Platelet Activating Factor; Quinolinium Compounds | 1990 |
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
Topics: Animals; BCG Vaccine; Endotoxins; Gastrointestinal Diseases; Hypotension; Lipopolysaccharides; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Shock, Septic; Tumor Necrosis Factor-alpha; Zymosan | 1990 |
Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
Topics: Azepines; Chemotaxis; Complement C5; Eosinophils; Furans; Humans; Leukotrienes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Quinolinium Compounds; Triazoles | 1990 |
Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether).
Topics: Animals; Azepines; Enterocolitis, Pseudomembranous; Hypoxia; Intestine, Small; Male; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Triazoles | 1990 |
Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.
Topics: Animals; Cyclosporins; Dinoprostone; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunization; Male; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred ACI; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Heterologous; Transplantation, Heterotopic | 1990 |
Embryo-deprived platelet-activating factor is essential for establishment of pregnancy in the mouse.
Topics: Animals; Embryo Implantation; Embryo, Mammalian; Epoprostenol; Female; Humans; Iloprost; Mice; Platelet Activating Factor; Pregnancy; Pregnancy, Animal; Quinolinium Compounds; Time Factors | 1987 |
Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos.
Topics: Alprazolam; Animals; Capillary Permeability; Embryo Implantation; Epoprostenol; Estradiol; Female; Iloprost; Mice; Platelet Activating Factor; Progesterone; Quinolinium Compounds; Uterus | 1988 |
The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion.
Topics: Acute Disease; Animals; Blood Gas Analysis; Cardiac Complexes, Premature; Coronary Disease; Disease Models, Animal; Diterpenes; Dogs; Drug Evaluation, Preclinical; Electrocardiography; Ginkgolides; Hemodynamics; Hydrogen-Ion Concentration; Lactones; Myocardial Reperfusion; Oxygen; Platelet Activating Factor; Platelet Count; Quinolinium Compounds; Random Allocation; Tachycardia; Time Factors; Ventricular Fibrillation | 1989 |
Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
Topics: Animals; Blood Platelets; In Vitro Techniques; Molecular Weight; Phospholipid Ethers; Phosphoproteins; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Quinolines; Quinolinium Compounds; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetradecanoylphorbol Acetate; Thrombin; Type C Phospholipases | 1989 |
Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigen.
Topics: Animals; Ascaris; Asthma; Drug Therapy, Combination; Female; Immunoglobulin E; Indazoles; Macaca mulatta; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyrazoles; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Immunologic; Receptors, Leukotriene; SRS-A | 1989 |
Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Calcimycin; Endotoxins; Epoprostenol; Escherichia coli; Female; Horses; Macrophages; Male; Peritoneal Cavity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane A2; Thromboxane B2 | 1989 |
Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity.
Topics: Animals; Dose-Response Relationship, Drug; Guinea Pigs; Lung; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 1989 |
Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
Topics: Animals; Blood Platelets; Enzyme Activation; In Vitro Techniques; Phosphatidylinositols; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Quinolines; Quinolinium Compounds; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Type C Phospholipases | 1989 |
Spermicidal effect of antagonists of platelet-activating factor.
Topics: Animals; Female; Fertilization; Injections; Male; Platelet Activating Factor; Quinolinium Compounds; Rabbits; Sperm Agglutination; Sperm Motility; Spermatocidal Agents; Time Factors; Vagina | 1989 |
Inhibition of vasoconstriction by platelet activating factor in the in situ blood perfused rat mesentery.
Topics: Angiotensin II; Animals; Blood Pressure; Electric Stimulation; Male; Norepinephrine; Platelet Activating Factor; Prazosin; Quinolinium Compounds; Rats; Rats, Inbred Strains; Serotonin; Splanchnic Circulation; Vasoconstriction | 1989 |
Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma.
Topics: Animals; Dogs; Hypersensitivity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1987 |
Lipoxygenase metabolites mediate increased airways responsiveness to histamine after acute platelet activating factor exposure in the guinea-pig.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Airway Resistance; Animals; Aspirin; Bronchi; Chromones; Female; Guinea Pigs; Histamine; Leukotriene B4; Lipoxygenase; Lung Compliance; Male; Platelet Activating Factor; Pyrazoles; Quinolinium Compounds; SRS-A | 1988 |
Pharmacologic modulation of experimental postischemic hepatic function.
Topics: Animals; Bile; Disease Models, Animal; Drug Evaluation, Preclinical; Hot Temperature; Ibuprofen; Ischemia; Liver; Male; Microscopy, Electron; Perfusion; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Reperfusion Injury; Superoxide Dismutase; Transaminases | 1989 |
Platelet-activating factor both stimulates and "primes" human polymorphonuclear leukocyte actin filament assembly.
Topics: Actin Cytoskeleton; Actins; Calcimycin; Calcium; Cytoskeleton; Drug Synergism; Egtazic Acid; Humans; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pertussis Toxin; Platelet Activating Factor; Quinolinium Compounds; Time Factors; Virulence Factors, Bordetella | 1987 |
Effects of platelet-activating factor antagonist SRI 63-441 on endotoxemia in sheep.
Topics: Animals; Endotoxins; Hemodynamics; Leukopenia; Lymph; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Pulmonary Gas Exchange; Quinolinium Compounds; Sheep; Toxemia | 1988 |
Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs.
Topics: Angiotensin II; Animals; Furans; Hypoxia; In Vitro Techniques; Male; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Quinolinium Compounds; Rats; Rats, Inbred Strains; Vasoconstriction | 1988 |
The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation.
Topics: Animals; Coronary Disease; Diterpenes; Dogs; Female; Ginkgolides; Heart; Lactones; Male; Myocardial Reperfusion Injury; Platelet Activating Factor; Platelet Aggregation; Quinolinium Compounds | 1988 |
A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation.
Topics: Animals; Aqueous Humor; Capillary Permeability; Dinoprostone; Eye; Female; Flurbiprofen; Inflammation; Interleukin-1; Leukocyte Count; Platelet Activating Factor; Prednisolone; Prostaglandins E; Proteins; Quinolinium Compounds; Rabbits; Recombinant Proteins | 1988 |
Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist.
Topics: Animals; Anterior Chamber; Aqueous Humor; Capillary Permeability; Dexamethasone; Dinoprostone; Drug Synergism; Endophthalmitis; Endotoxins; Eye; Female; Indomethacin; Platelet Activating Factor; Prostaglandins E; Punctures; Quinolinium Compounds; Rabbits | 1988 |
Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441.
Topics: Adenosine; Allopurinol; Animals; Glutathione; Hypertonic Solutions; Insulin; Liver; Male; Organ Preservation; Organ Preservation Solutions; Platelet Activating Factor; Quinolinium Compounds; Raffinose; Rats; Rats, Inbred Lew; Solutions; Time Factors | 1988 |
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response.
Topics: Alprostadil; Animals; Biopsy; Dogs; Epoprostenol; Female; Graft Survival; Inflammation; Kidney; Kidney Transplantation; Male; Platelet Activating Factor; Platelet Count; Quinolinium Compounds; Renal Circulation; Swine; Transplantation, Heterologous | 1987 |
Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
Topics: Animals; Endotoxins; Glucose; Hemodynamics; Hormones; Male; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains | 1987 |
Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
Topics: Animals; Blood Pressure; Endotoxins; Hemodynamics; Lung; Male; Neutropenia; Phospholipid Ethers; Platelet Activating Factor; Pulmonary Circulation; Quinolinium Compounds; Rats; Rats, Inbred Strains; Salmonella enteritidis; Thiazoles; Time Factors; Vasoconstriction; Vinblastine | 1987 |
Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog.
Topics: Animals; Blood Pressure; Dogs; Endotoxins; Feces; Male; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains | 1987 |
Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys.
Topics: Aerosols; Animals; Antigens, Helminth; Ascaris; Female; Lung; Macaca mulatta; Male; Platelet Activating Factor; Quinolinium Compounds; Respiratory Function Tests | 1987 |
Negative inotropic effect of platelet-activating factor on human myocardium: a pharmacological study.
Topics: Calcium; Depression, Chemical; Dose-Response Relationship, Drug; Humans; Indomethacin; Myocardial Contraction; Phospholipid Ethers; Platelet Activating Factor; Quinolinium Compounds; SRS-A; Thiazoles | 1987 |
Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441.
Topics: Animals; Blood Pressure; Cebus; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Hematocrit; Hemodynamics; Hypotension; Kinetics; Lung; Male; Platelet Activating Factor; Quinolinium Compounds; Rats; Species Specificity | 1986 |
The role of platelet-activating factor in lipopolysaccharide-induced myocardial depression in guinea pigs.
Topics: Animals; Azepines; Depression, Chemical; Drug Interactions; Escherichia coli; Female; Guinea Pigs; Isoproterenol; Lipopolysaccharides; Male; Myocardial Contraction; Phenylephrine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Time Factors; Triazoles | 1995 |
Three drugs inhibit phospholipase A2-induced high permeability of endothelial monolayers.
Topics: Animals; Calcitriol; Capillary Permeability; Endothelium, Vascular; Female; Indomethacin; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Sprague-Dawley | 1994 |
Role of R-type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet-activating factor.
Topics: Animals; Arginine; Azepines; Calcium Channels; Isradipine; Male; Mesenteric Arteries; Mesenteric Veins; NG-Nitroarginine Methyl Ester; Perfusion; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Wistar; Triazoles | 1994 |
Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
Topics: Animals; Azepines; Endotoxins; Lipopolysaccharides; Lung; Male; Neutrophils; Peroxidase; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Triazoles; Tumor Necrosis Factor-alpha | 1994 |
Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor.
Topics: Animals; Azepines; Drug Synergism; Endotoxins; Enzyme Activation; Intestines; Lipopolysaccharides; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinolinium Compounds; Stimulation, Chemical; Triazoles; Tumor Necrosis Factor-alpha | 1994 |
Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia.
Topics: Animals; Antithrombin III; Blood Pressure; Body Temperature; Endotoxins; Heart Rate; Hematocrit; Horse Diseases; Horses; Leukocyte Count; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2; Tumor Necrosis Factor-alpha | 1993 |
Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin.
Topics: Animals; Azepines; Cadherins; Cytoskeleton; Dextrans; Enzyme Inhibitors; Epithelium; Glucose; Hypotension; Intestinal Mucosa; Intestines; Leukocytosis; Male; Permeability; Phosphorylation; Phosphotyrosine; Platelet Activating Factor; Protein-Tyrosine Kinases; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Triazoles; Tyrosine; Tyrphostins | 2000 |